Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morriss

Showing results (651-660 of 704) with videos related to

Pageof 71
Sort By:
Health Technology Assessment (Winchester, England)|April 30, 2009
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) studyT Kendrick, J Chatwin, C Dowrick, et al.
Immunity|October 12, 2022
Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune responseSophia Liu, J Bryan Iorgulescu, Shuqiang Li, et al.
Bjpsych Open|April 13, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trialNataša Perić, Susanne Mayer, Timea Helter, et al.
The American Journal of Psychiatry|April 7, 2018
The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled TrialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Lamotrigine for people with borderline personality disorder: a RCTMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Plos One|June 26, 2026
Mental health of healthcare workers in England during the first three years of the COVID-19 pandemic: The NHS CHECK study cohortDanielle Lamb, Hannah Scott, Ewan Carr, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Nature Medicine|January 16, 2024
Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trialRichard Morriss, Paul M Briley, Lucy Webster, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2021
Apoptotic Ablation of Platelets Reduces Atherosclerosis in Mice With DiabetesMan K S Lee, Michael J Kraakman, Dragana Dragoljevic, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 28, 2012
Nprl3 is required for normal development of the cardiovascular systemMonika S Kowalczyk, Jim R Hughes, Christian Babbs, et al.
Pageof 71

Showing results (651-660 of 704) with videos related to

Sort By:
Pageof 71
Health Technology Assessment (Winchester, England)|April 30, 2009
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) studyT Kendrick, J Chatwin, C Dowrick, et al.
Immunity|October 12, 2022
Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune responseSophia Liu, J Bryan Iorgulescu, Shuqiang Li, et al.
Bjpsych Open|April 13, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trialNataša Perić, Susanne Mayer, Timea Helter, et al.
The American Journal of Psychiatry|April 7, 2018
The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled TrialMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Lamotrigine for people with borderline personality disorder: a RCTMike J Crawford, Rahil Sanatinia, Barbara Barrett, et al.
Plos One|June 26, 2026
Mental health of healthcare workers in England during the first three years of the COVID-19 pandemic: The NHS CHECK study cohortDanielle Lamb, Hannah Scott, Ewan Carr, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Nature Medicine|January 16, 2024
Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trialRichard Morriss, Paul M Briley, Lucy Webster, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2021
Apoptotic Ablation of Platelets Reduces Atherosclerosis in Mice With DiabetesMan K S Lee, Michael J Kraakman, Dragana Dragoljevic, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 28, 2012
Nprl3 is required for normal development of the cardiovascular systemMonika S Kowalczyk, Jim R Hughes, Christian Babbs, et al.
Pageof 71